Effect of SARS-CoV-2 infection on seizure, anxiety, and depression in 107 patients with epilepsy.

Autor: Zhou S; Department of Neurology Ward 1, Xinyang Central Hospital, National Secondary Epilepsy Center, Xinyang 464000, Henan, China., Zhang D; Department of General ICU,Xinyang Central Hospital ,Xinyang Key Laboratory of Critical Care Medicine, Xinyang, 464000, Henan, China., Chang J; Department of Neurology Ward 1, Xinyang Central Hospital, National Secondary Epilepsy Center, Xinyang 464000, Henan, China., Xia Z; Department of Neurology Ward 1, Xinyang Central Hospital, National Secondary Epilepsy Center, Xinyang 464000, Henan, China., Li J; Department of Emergency Xinyang Central Hospital, Xinyang 464000, Henan, China., Ni M; Department of Neurology Ward 1, Xinyang Central Hospital, National Secondary Epilepsy Center, Xinyang 464000, Henan, China., Li H; Department of Neurology Ward 1, Xinyang Central Hospital, National Secondary Epilepsy Center, Xinyang 464000, Henan, China. Electronic address: lh1500@126.com.
Jazyk: angličtina
Zdroj: Epilepsy & behavior : E&B [Epilepsy Behav] 2023 Aug; Vol. 145, pp. 109290. Date of Electronic Publication: 2023 Jun 15.
DOI: 10.1016/j.yebeh.2023.109290
Abstrakt: Objective: To study the effects of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) on epileptic seizures, anxiety, and depression in patients with epilepsy.
Methods: Based on the inclusion and exclusion criteria, an ambispective cohort study was hereby conducted on patients with epilepsy infected with SARS-CoV-2 who visited the outpatient and ward of the Department of Neurology of Xinyang Central Hospital from December 2022 (when the domestic epidemic prevention and control policy was lifted) to February 2023. A face-to-face questionnaire survey involving factors including basic information, vaccination with inactivated COVID-19 vaccines, number of seizures within 2 months before and after SARS-CoV-2 infection, and scores of anxiety and depression was carried out.
Results: A total of 107 patients with epilepsy satisfying the inclusion and exclusion criteria completed the follow-up after 2 months. It was found that enrolled patients maintained the original dose of antiepileptic drugs, but the frequency of seizures after COVID-19 infection could not be controlled. After infection with SARS-CoV-2, the frequency of seizures in patients with epilepsy in 2 months increased compared with that before infection (P < 0.05). Meanwhile, compared with the vaccinated group, the high-frequency seizure rate of epilepsy in the unvaccinated group was higher. (P < 0.05), and the anxiety and depression scores of patients with epilepsy were worse than those before they were infected (P < 0.05).
Conclusion: Being infected with SARS-CoV-2 can increase the number of seizures and aggravate the degree of anxiety and depression in patients with epilepsy. The inactivated vaccine is protective, and the inactivated SARS-CoV-2 vaccine can reduce the rate of high-frequency seizures.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023. Published by Elsevier Inc.)
Databáze: MEDLINE
Externí odkaz: